XML 45 R34.htm IDEA: XBRL DOCUMENT v3.25.3
Segment Reporting - Segment and Consolidated Net Income (Details) - USD ($)
$ in Thousands
 3 Months Ended 9 Months Ended
Oct. 03, 2025
Sep. 27, 2024
Oct. 03, 2025
Sep. 27, 2024
Segment Reporting Information [Line Items]        
Revenues $ 597,755 $ 539,542 $ 1,721,463 $ 1,601,946
Less:        
Cost of goods sold 18,574 17,328 57,216 56,251
Interest income (15,922) (18,709) (51,787) (55,861)
Provision for income taxes 58,835 36,782 150,476 115,461
Net income 193,578 117,973 538,042 381,406
Reportable Segment        
Segment Reporting Information [Line Items]        
Revenues 597,755 539,542 1,721,463 1,601,946
Less:        
Cost of goods sold 18,574 17,328 57,216 56,251
Drug discovery 23,838 25,221 63,448 72,807
Development 133,645 158,365 421,021 477,486
Selling, general, and administrative 103,129 97,542 336,835 312,144
Other segment items 82,078 105,040 206,212 242,252
Interest income (15,922) (18,709) (51,787) (55,861)
Provision for income taxes 58,835 36,782 150,476 115,461
Net income $ 193,578 $ 117,973 $ 538,042 $ 381,406